Upon receipt, the device was interrogated, revealing the battery status bos.The device was implanted for 20 days and 5 charging cycles were recorded to the device memory.The memory content of the device was inspected.The inspection revealed no indications of a device malfunction.There was no indication towards the root cause for the reported high current consumption.The ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be flawless in amplitude and frequency as programmed.A fibrillation signal was applied and the device delivered a defibrillation shock as specified, documenting a correct sensing and shock delivery.In particular, the specified energy level was reached.The current consumption of the icd was verified and was within expectation.The impedance measurement functions of the device were tested under in vivo conditions.However, the impedance measurement functions proved to be flawless.In summary, the device was fully functional.There was no indication of device malfunction.Specifically the impedance measurement functions as well as the current consumption were normal and expected.
|